Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
2-deoxy-2-[18F]fluoro-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) is indicated in head-and-neck cancer for the initial workup when clinically indicated (e. g., large tumors, clinically positive neck, cervical adenopathy from an unknown primary, etc.), for the assessme...
Main Authors: | Tim Van den Wyngaert, Stijn De Schepper, Laurens Carp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01458/full |
Similar Items
-
FDG-PET AND PET/CT - Part I
by: Amol M Takalkar, et al.
Published: (2007-07-01) -
Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
by: Frank Hofheinz, et al.
Published: (2019-03-01) -
Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
by: C. Pisani, et al.
Published: (2021-03-01) -
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
by: Nils Helsen, et al.
Published: (2017-01-01) -
Prognostic value of 18F-FDG PET/CT parameters and histopathologic variables in head and neck cancer
by: Hale Aslan, et al.
Published: (2021-07-01)